According to a new report North America mHealth Market, published by KBV research, the North America mHealth Market would witness market growth of 30.1% CAGR during the forecast period (2020-2026).
The US market dominated the North America Healthcare Providers Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is poised to grow at a CAGR of 34.3% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 33.8% during (2020 - 2026).
The Services market dominated the Canada mHealth Market by Type in 2019, thereby, achieving a market value of $5543.4 million by 2026, growing at a CAGR of 32.2 % during the forecast period. The Devices market is expected to witness a CAGR of 33.3% during (2020 - 2026).
The Cardiovascular Diseases market dominated the Mexico mHealth Market by Applications in 2019, growing at a CAGR of 31.3 % during the forecast period. The Diabetes market is exhibiting a CAGR of 31.2% during (2020 - 2026). The Respiratory market is projected to grow at a CAGR of 33.1% during (2020 - 2026). Additionally, The Neurology market would showcase a CAGR of 32.6% during (2020 - 2026).
Report Structural Insights: https://www.kbvresearch.com/north-america-mhealth-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
By Type
By Services
By Devices
By Stakeholders
Content Players
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
